Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLCO Bausch + Lomb	$14.63 +0.6%	$13.90	$10.45 ▼ $21.69	$5.15B	0.62	690,227 shs	464,593 shs
GKOS Glaukos	$95.86 -0.7%	$95.62	$77.10 ▼ $163.71	$5.54B	0.78	846,228 shs	488,453 shs
INSP Inspire Medical Systems	$93.86 +2.6%	$113.86	$73.92 ▼ $225.00	$2.70B	1.22	1.73 million shs	656,389 shs
LMAT LeMaitre Vascular	$95.36 +0.1%	$87.40	$71.42 ▼ $109.58	$2.16B	0.79	223,607 shs	93,841 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLCO Bausch + Lomb	+0.40%	-1.96%	+6.42%	+27.47%	-9.17%
GKOS Glaukos	-0.71%	+1.75%	+1.96%	+1.62%	-29.20%
INSP Inspire Medical Systems	+2.72%	-2.02%	-28.60%	-32.00%	-48.77%
LMAT LeMaitre Vascular	+0.09%	-4.95%	+16.34%	+16.05%	+7.10%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLCO Bausch + Lomb	1.1591 of 5 stars	2.1	2.0	0.0	0.0	0.0	0.0	2.5
GKOS Glaukos	4.6774 of 5 stars	4.4	4.0	0.0	4.4	2.7	1.7	0.6
INSP Inspire Medical Systems	4.9807 of 5 stars	4.3	4.0	0.0	4.8	4.0	1.7	3.1
LMAT LeMaitre Vascular	2.6149 of 5 stars	1.2	2.0	3.3	0.0	2.3	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLCO Bausch + Lomb	2.18	Hold	$15.56	6.30% Upside
GKOS Glaukos	2.79	Moderate Buy	$127.42	32.92% Upside
INSP Inspire Medical Systems	2.54	Moderate Buy	$165.62	76.44% Upside
LMAT LeMaitre Vascular	2.40	Hold	$97.60	2.35% Upside

Current Analyst Ratings Breakdown

Latest LMAT, GKOS, BLCO, and INSP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	GKOS Glaukos	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/15/2025	INSP Inspire Medical Systems	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$116.00 ➝ $97.00
8/12/2025	BLCO Bausch + Lomb	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
8/6/2025	LMAT LeMaitre Vascular	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$92.00 ➝ $95.00
8/6/2025	LMAT LeMaitre Vascular	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$95.00
8/5/2025	INSP Inspire Medical Systems	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $150.00
8/5/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$174.00 ➝ $101.00
8/5/2025	INSP Inspire Medical Systems	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $230.00
8/5/2025	INSP Inspire Medical Systems	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$215.00 ➝ $180.00
8/5/2025	INSP Inspire Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$233.00 ➝ $150.00
8/5/2025	INSP Inspire Medical Systems	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$190.00 ➝ $125.00

(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLCO Bausch + Lomb	$4.89B	1.06	$1.88 per share	7.77	$18.39 per share	0.80
GKOS Glaukos	$383.48M	14.34	N/A	N/A	$13.34 per share	7.19
INSP Inspire Medical Systems	$802.80M	3.46	$1.75 per share	53.53	$22.92 per share	4.10
LMAT LeMaitre Vascular	$219.86M	9.82	$2.39 per share	39.88	$16.02 per share	5.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLCO Bausch + Lomb	-$317M	-$0.78	N/A	15.24	1.48	-5.58%	2.33%	1.12%	10/29/2025 (Estimated)
GKOS Glaukos	-$146.37M	-$1.65	N/A	N/A	N/A	-21.43%	-8.59%	-6.61%	11/3/2025 (Estimated)
INSP Inspire Medical Systems	$53.51M	$1.73	54.26	29.15	2.85	6.17%	10.38%	8.93%	11/3/2025 (Estimated)
LMAT LeMaitre Vascular	$44.04M	$2.06	46.29	43.94	2.45	20.08%	13.67%	9.14%	10/30/2025 (Estimated)

Latest LMAT, GKOS, BLCO, and INSP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	LMAT LeMaitre Vascular	$0.57	$0.60	+$0.03	$0.60	$62.48 million	$63.15 million
8/4/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	$0.45	+$0.23	-$0.12	$214.50 million	$217.09 million
7/30/2025	Q2 2025	BLCO Bausch + Lomb	$0.06	$0.07	+$0.01	-$0.18	$1.25 billion	$1.28 billion
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	-$0.24	+$0.02	-$0.34	$115.49 million	$124.12 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLCO Bausch + Lomb	N/A	N/A	N/A	N/A	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$0.80	0.84%	N/A	38.83%	14 Years

Latest LMAT, GKOS, BLCO, and INSP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2025	LMAT LeMaitre Vascular	quarterly	$0.20	0.9%	8/21/2025	8/21/2025	9/4/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLCO Bausch + Lomb	0.76	1.55	0.98
GKOS Glaukos	0.09	5.51	4.69
INSP Inspire Medical Systems	N/A	6.14	4.84
LMAT LeMaitre Vascular	0.46	13.96	11.74

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLCO Bausch + Lomb	11.07%
GKOS Glaukos	99.04%
INSP Inspire Medical Systems	94.91%
LMAT LeMaitre Vascular	84.64%

Insider Ownership

Company	Insider Ownership
BLCO Bausch + Lomb	0.76%
GKOS Glaukos	5.80%
INSP Inspire Medical Systems	4.10%
LMAT LeMaitre Vascular	9.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLCO Bausch + Lomb	13,500	353.99 million	351.30 million	Optionable
GKOS Glaukos	780	57.35 million	54.02 million	Optionable
INSP Inspire Medical Systems	1,246	29.57 million	28.36 million	Optionable
LMAT LeMaitre Vascular	490	22.64 million	20.49 million	Optionable

LMAT, GKOS, BLCO, and INSP Headlines

Recent News About These Companies

Comerica Bank Raises Stock Holdings in LeMaitre Vascular, Inc. $LMAT

August 29 at 5:47 AM | marketbeat.com

Nuveen LLC Takes Position in LeMaitre Vascular, Inc. $LMAT

August 29 at 3:36 AM | marketbeat.com

LeMaitre to Participate at Upcoming Investor Conferences in September

August 28 at 4:35 PM | globenewswire.com

Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes"

August 27 at 1:45 PM | zacks.com

AlphaQuest LLC Grows Stock Position in LeMaitre Vascular, Inc. $LMAT

August 27 at 5:56 AM | marketbeat.com

Credit Agricole S A Has $1.58 Million Stock Position in LeMaitre Vascular, Inc. $LMAT

August 27 at 4:27 AM | marketbeat.com

3 Inflated Stocks We’re Skeptical Of

August 26, 2025 | msn.com

FDA posts warning letter sent to LeMaitre over site violations

August 26, 2025 | msn.com

Algert Global LLC Has $625,000 Holdings in LeMaitre Vascular, Inc. $LMAT

August 26, 2025 | marketbeat.com

Bond market trumps Fed in impact on small cap stocks – Kayne Anderson Rudnick

August 25, 2025 | msn.com

CW Advisors LLC Sells 16,826 Shares of LeMaitre Vascular, Inc. $LMAT

August 25, 2025 | marketbeat.com

Charles Schwab Investment Management Inc. Sells 9,163 Shares of LeMaitre Vascular, Inc. $LMAT

August 25, 2025 | marketbeat.com

Invesco Ltd. Purchases 60,438 Shares of LeMaitre Vascular, Inc. $LMAT

August 24, 2025 | marketbeat.com

7 Top Trade Setups You Need to See | MSFT, LMAT, APP, IWM, ACN, BSX, UNH

August 22, 2025 | msn.com

Aptus Capital Advisors LLC Purchases Shares of 53,428 LeMaitre Vascular, Inc. $LMAT

August 22, 2025 | marketbeat.com

Public Sector Pension Investment Board Acquires 13,953 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

August 19, 2025 | marketbeat.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $98.00 Average Price Target from Brokerages

August 19, 2025 | americanbankingnews.com

Russell Investments Group Ltd. Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

August 18, 2025 | marketbeat.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Moderate Buy" from Brokerages

August 17, 2025 | marketbeat.com

Cetera Investment Advisers Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

August 16, 2025 | marketbeat.com

David B. Roberts Sells 10,815 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock

August 15, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT, GKOS, BLCO, and INSP Company Descriptions

Bausch + Lomb NYSE:BLCO

$14.63 +0.08 (+0.57%)

Closing price 08/29/2025 03:59 PM Eastern

Extended Trading

$14.62 -0.01 (-0.09%)

As of 08/29/2025 06:52 PM Eastern

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Glaukos NYSE:GKOS

$95.86 -0.70 (-0.73%)

Closing price 08/29/2025 03:59 PM Eastern

Extended Trading

$95.80 -0.06 (-0.06%)

As of 08/29/2025 04:20 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Inspire Medical Systems NYSE:INSP

$93.86 +2.40 (+2.63%)

Closing price 08/29/2025 03:59 PM Eastern

Extended Trading

$92.75 -1.11 (-1.19%)

As of 08/29/2025 05:11 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LeMaitre Vascular NASDAQ:LMAT

$95.36 +0.09 (+0.09%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$95.28 -0.08 (-0.08%)

As of 08/29/2025 04:20 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time